IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates

Core Insights - IQVIA Holdings reported quarterly earnings of $3 per share, exceeding the Zacks Consensus Estimate of $2.96 per share, and showing an increase from $2.84 per share a year ago, resulting in an earnings surprise of +1.35% [1] - The company achieved revenues of $4.1 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.86% and reflecting a year-over-year increase from $3.9 billion [2] - IQVIA has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $3.40 on revenues of $4.24 billion, while for the current fiscal year, the estimate is $11.86 on revenues of $16.16 billion [7] - The trend of estimate revisions for IQVIA was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which IQVIA belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]